X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (82) 82
humans (68) 68
oncology (50) 50
female (35) 35
hematology (29) 29
aged (25) 25
male (25) 25
middle aged (25) 25
adult (21) 21
article (21) 21
mutation (18) 18
cancer (17) 17
models, biological (14) 14
radiation (14) 14
radiology, nuclear medicine & medical imaging (13) 13
biology (12) 12
biophysics (12) 12
research (12) 12
aged, 80 and over (11) 11
expression (11) 11
leukemia (11) 11
animals (10) 10
care and treatment (10) 10
dna damage (10) 10
gene expression (10) 10
myelodysplastic syndromes (10) 10
ribonucleotide reductase (10) 10
cells (9) 9
chemotherapy (9) 9
mice (9) 9
abridged index medicus (8) 8
acute myeloid-leukemia (8) 8
analysis (8) 8
health aspects (8) 8
radiotherapy (8) 8
ribonucleotide reductases - metabolism (8) 8
therapy (8) 8
time factors (8) 8
treatment outcome (8) 8
biochemistry & molecular biology (7) 7
biology, miscellaneous (7) 7
decitabine (7) 7
dna-damage (7) 7
double-strand breaks (7) 7
genetic aspects (7) 7
hematology, oncology and palliative medicine (7) 7
hemic and lymphatic diseases (7) 7
leukemia, myeloid, acute - genetics (7) 7
myelodysplastic syndromes - genetics (7) 7
proto-oncogene proteins - genetics (7) 7
research article (7) 7
space life sciences (7) 7
tumors (7) 7
apoptosis (6) 6
cell line, tumor (6) 6
cervical cancer (6) 6
dna repair (6) 6
drug administration schedule (6) 6
enzyme inhibitors - pharmacology (6) 6
gene (6) 6
gene mutations (6) 6
ionizing radiation (6) 6
ionizing-radiation (6) 6
leukemia, myelogenous, chronic, bcr-abl positive - epidemiology (6) 6
medicine, research & experimental (6) 6
models, statistical (6) 6
mutations (6) 6
ribonucleotide reductases - antagonists & inhibitors (6) 6
risk (6) 6
risk factors (6) 6
survival (6) 6
acute myeloid leukemia (5) 5
aml (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
azacitidine - analogs & derivatives (5) 5
carcinoma (5) 5
clinical trials (5) 5
cytotoxicity (5) 5
deoxyribonucleic acid--dna (5) 5
dna (5) 5
dna methylation (5) 5
dna-binding proteins - genetics (5) 5
dose-response relationship, drug (5) 5
epigenetics (5) 5
gene-expression (5) 5
genetics (5) 5
irradiation (5) 5
kinetics (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - etiology (5) 5
mammalian-cells (5) 5
multiple-myeloma (5) 5
neoplasms (5) 5
p53 (5) 5
phosphorylation (5) 5
prognosis (5) 5
radiation dosage (5) 5
stem cells (5) 5
usage (5) 5
acute lymphoblastic-leukemia (4) 4
algorithms (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 01/2017, Volume 49, Issue 2, pp. 204 - 212
Journal Article
BMC Systems Biology, ISSN 1752-0509, 02/2008, Volume 2, Issue 1, pp. 15 - 15
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2019, Volume 94, Issue 7, pp. 780 - 785
Compared to age‐matched controls, cancer patients have increased risk of bleeding when treated with anticoagulation. However, there are little data regarding... 
Cancer patients | Chronic kidney failure | Oncology, Experimental | Anticoagulants (Medicine) | Metastasis | Research | Health aspects | Risk factors | Cancer | Thrombocytopenia | Anticoagulants | Warfarin | Kidneys | Kidney diseases | Platelets | Bleeding | Tumors | Metastases
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2018, Volume 182, Issue 5, pp. 730 - 733
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2015, Volume 125, Issue 3, pp. 1043 - 1055
Journal Article
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2017, Volume 109, Issue 8
Journal Article
npj Aging and Mechanisms of Disease, ISSN 2056-3973, 12/2019, Volume 5, Issue 1, pp. 2 - 13
A high-throughput anti-aging drug screen was developed that simultaneously measures senescence-associated β-galactosidase activity and proliferation. Applied... 
NAD | Cytochrome c | Senescence | Catalysts | NAD(P)H dehydrogenase | Quinone | Fibroblasts | Aging | Glutathione
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2019, Volume 185, Issue 5, pp. 935 - 939
Compound heterozygous germline mutations in CTC 1 gene have been found in patients with atypical dyskeratosis congenita ( DC ), whereas heterozygous carriers... 
bone marrow failure | CTC | germline variant | telomere length | heterozygous | CTC1 | VARIANTS | GENE | MUTATIONS | HEMATOLOGY | Telomeres | Aplastic anemia | Bone marrow | Dyskeratosis | Mutation | Anemia | Myelodysplastic syndrome
Journal Article
PLoS Medicine, ISSN 1549-1277, 09/2017, Volume 14, Issue 9, pp. e1002382 - e1002382
Background Sickle cell disease (SCD), a congenital hemolytic anemia that exacts terrible global morbidity and mortality, is driven by polymerization of mutated... 
CYTOSINE-ARABINOSIDE | MEDICINE, GENERAL & INTERNAL | THROMBIN GENERATION | GAMMA-GLOBIN SYNTHESIS | DNA METHYLATION | BETA-THALASSEMIA-INTERMEDIA | RED-BLOOD-CELLS | ACUTE MYELOID-LEUKEMIA | FETAL HEMOGLOBIN-SYNTHESIS | HISTONE DEACETYLASE INHIBITORS | MYELODYSPLASTIC SYNDROMES | Gene Silencing - drug effects | Humans | Middle Aged | Enzyme Inhibitors - pharmacology | Tetrahydrouridine - administration & dosage | Azacitidine - analogs & derivatives | Decitabine | Male | Treatment Outcome | Anemia, Sickle Cell - drug therapy | Fetal Hemoglobin - drug effects | Tetrahydrouridine - pharmacology | Enzyme Inhibitors - administration & dosage | Gene Expression Regulation - drug effects | Young Adult | Azacitidine - pharmacology | Adult | Female | Epigenesis, Genetic - drug effects | Drug Therapy, Combination | Anemia, Sickle Cell - genetics | Azacitidine - administration & dosage | Usage | Care and treatment | Sickle cell anemia | Myelocytic leukemia | Clinical trials | Polymerization | Nonlymphoid leukemia | Bilirubin | Research | Health aspects | Risk factors | C-reactive protein | Erythrocytes | Cytotoxicity | Leukocytes (mononuclear) | Cancer therapies | Blood | Hemoglobin | Bioindicators | Drug dosages | Deoxyribonucleic acid--DNA | Anemia | Fetuses | DNMT1 protein | Leukocytes (neutrophilic) | Bioavailability | Gene expression | Patients | Hospitals | Biomarkers | DNA methyltransferase | Adults | Erythropoiesis | Health sciences | Toxicity | Leukemia | Gene regulation | Oncology | Randomization | Red blood cells | Hemolytic anemia | Quality | Cell cycle | DNA methylation | Peripheral blood mononuclear cells | Sickle cell disease | Supervision | CpG islands | Hematology | Blood cells | Radioactive half-life | Reticulocytes | Pharmacology | Morbidity | Medicine | Depletion | Epigenetics | Methylation | Platelets | Cytidine deaminase | Apoptosis | 5-aza-2'-deoxycytidine | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article